IQuest Enterprises to acquire active pharma ingredient business of Viatris

October 2, 2023
News
1 mins read

Source: Business Standard

The investment firm has entered into a definitive agreement to acquire the API operations of global pharmaceutical major Viatris in India, IQuest Enterprises said in a statement on Monday

Multi-sector investment firm IQuest Enterprises will acquire the active pharmaceutical ingredients (API) business of Viatris in India for an undisclosed amount.

The investment firm has entered into a definitive agreement to acquire the API operations of global pharmaceutical major Viatris in India, IQuest Enterprises said in a statement on Monday.

IQuest emerged as the preferred investor following a global competitive bid, it added.

As part of the deal, the company will acquire six API manufacturing facilities, three each in Vizag and Hyderabad, an R&D facility in Hyderabad, and third-party API sales.

“We are excited about our largest investment in the pharmaceutical sector till date. Our investment comes at an opportune time when India is drawing significant attention amongst the global pharma industry,” IQuest Enterprises Executive Director Gunupati Swathi Reddy noted.

IQuest Enterprises is a multi-sector investment company. It has invested in various entities like AIG Hospitals, CARE Hospitals, and Celon Laboratories.

In a separate statement, US-headquartered Viatris stated that it has executed an agreement to divest its API business in India to IQuest Enterprises.

Viatris will, however, retain some selective R&D capabilities in API, it stated.

Pharmaways

Pharmaways Global Private Limited is a company established in 2022. Headed by a group of professionals with over 25 years of experience. A team of professionals who have excelled in their respective fields of Pharma, Legal & Information Technology. We have global exposure and hands-on experience of the global Pharma industry. We are in pursuit of bringing the global Pharma Industry on a platform where they can connect, collaborate and work towards mutual growth. We have taken a step into the future by innovating a technology that will help global Pharma players to empower, excel and accelerate in their business. A platform that has been developed exclusively for the Pharma fraternity. We are a New Delhi based company with overseas offices in America and the United Kingdom.